|
|
|
|
 |
|||
|
|||
doi:10.1369/jhc.5A6836.2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Volume 54 (5): 585-591, 2006
Copyright ©The Histochemical Society, Inc.
Terminal 
1,4-linked N-acetylglucosamine in Helicobacter pylori–associated Intestinal Metaplasia of the Human Stomach and Gastric Carcinoma Cell Lines
Institute of Molecular Pathology and Immunology (BF,NTM,LD,CAR) and Medical Faculty (LD,CAR), University of Porto, Porto, Portugal, and Department of Pathology, Shinshu University School of Medicine, Matsumoto, Japan (JN)
Correspondence to: Celso A. Reis, Institute of Molecular Pathology and Immunology, University of Porto (IPATIMUP), Rua Dr. Roberto Frias, s/n; 4200-465, Porto, Portugal. E-mail: celso.reis{at}ipatimup.pt
 |
Summary |
|---|
 Top Summary IntroductionMaterials and MethodsResultsDiscussionLiterature Cited |
|---|
Helicobacter pylori (Hp) infection is associated with the development of gastric lesions including gastritis, intestinal metaplasia (IM), and gastric carcinoma. In humans, Hp is found almost exclusively in the foveolar epithelium of the gastric mucosa and rarely colonizes the deeper portions where mucous cells of the glands produce mucins with terminal
1,4-GlcNAc O-glycans. This structure exerts antimicrobial activity against Hp. The development of IM in the stomach is characterized by Hp clearance from the metaplastic glands and by major alterations in the expression of mucins and mucin–carbohydrates. The present work evaluated whether terminal 1,4-GlcNAc and sialyl-Tn antigen are implicated in the process of Hp clearance from metaplastic glands by analyzing the expression of these antigens in different types of IM—complete (n=12) and incomplete (n=8)—and in gastric cell lines. Terminal 1,4-GlcNAc was not detected in IM except in a single foci of one case, indicating that this structure is not implicated in the clearance of Hp from IM, in contrast to what is observed in normal gastric mucosa. None of the gastric carcinoma cell lines studied showed terminal 1,4-GlcNAc, suggesting that they do not display a gastric gland mucous cell phenotype and therefore are useful models for in vitro Hp studies. Finally, sialyl-Tn antigen colocalizes with MUC2 mucin and is present in all cases of complete and incomplete IM, suggesting that either or both can be implicated in Hp clearance from IM. (J Histochem Cytochem 54:585–591, 2006)
Key Words: N-acetylglucosamine • intestinal metaplasia • Helicobacter pylori • sialyl-Tn • O-glycosylation
|
Introduction |
|---|
|
TopSummaryIntroductionMaterials and MethodsResultsDiscussionLiterature Cited |
|---|
HELICOBACTER PYLORI (Hp) is a prevalent bacterium that colonizes the human gastric mucosa (Suerbaum and Michetti 2002
). Most infected individuals remain asymptomatic, but a fraction of these individuals will evolve to chronic atrophic gastritis, intestinal metaplasia (IM) and, in some cases, gastric carcinoma (Parsonnet et al. 1991; Correa 1992; Wang et al. 1998; Suerbaum and Michetti 2002). As a result, in 1994 the International Agency for Research on Cancer (IARC; Lyon, France) classified Hp infection as a class I carcinogenic agent.
Hp is observed almost exclusively colonizing the gastric mucosa. It is also found in the duodenal mucosa whenever there is gastric metaplasia (Futami et al. 1999), suggesting that the colonization is dependent on the gastric microenvironment. In gastric mucosa, the exclusive adherence of Hp to surface mucous cell-type cells also indicates that the bacteria specifically recognize epithelial cell surface constituents. Two carbohydrate structures, Lewis b expressed on mucins and sialyl dimeric Lewis X expressed on glycolipids, have been described as specific ligands for Hp adhesins, BabA, and SabA, respectively (Ilver et al. 1998; Mahdavi et al. 2002).
Absence of colonization of the deeper portions of gastric mucosa has been attributed to the mucin glycosylation of gland mucous cells, which produce mucin carbohydrate chains having terminal 1,4-GlcNAc residues attached to core 2-branched O-glycans [GlcNAc1
4Galß14GlcNAcß16(GlcNAc14Galß13)GalNAcSer/Thr] (Nakayama et al. 1999; Zhang et al. 2001). These terminal structures have been shown to exhibit antimicrobial activity against Hp due to the inhibition of the biosynthesis of cholesteryl--D-glucopyranoside, a major cell wall component of the bacteria (Kawakubo et al. 2004).
Development of gastric IM creates a microenvironment that is hostile to the bacterial colonization and generally leads to clearing of Hp from metaplastic glands (Craanen et al. 1992). Major alterations in mucin expression and their associated carbohydrate chains have been described in IM. These alterations include the aberrant expression of the MUC2 mucin and expression of the sialyl-Tn antigen, which are markers normally expressed in intestinal mucosa (David et al. 1992; Reis et al. 1998; Corfield et al. 2001).
The aim of this study was to characterize the expression pattern of the terminal 1,4-GlcNAc and the sialyl-Tn antigen in both complete IM and incomplete IM, to evaluate whether these glycans are implicated in the process of Hp clearance from metaplastic glands.
|
Materials and Methods |
|---|
|
TopSummaryIntroductionMaterials and MethodsResultsDiscussionLiterature Cited |
|---|
Human Tissue Samples
Gastric biopsies were obtained from individuals with non-ulcer dyspepsia. Gastric mucosas adjacent to carcinomas were obtained from individuals undergoing surgery at the Hospital S. João, Medical Faculty (Porto, Portugal). All specimens were fixed in 10% formalin and routinely embedded in paraffin wax. Serial sections were cut and used for immunohistochemistry and immunofluorescence. We evaluated 22 cases with IM that were classified as complete IM (n=14) and incomplete IM (n=8) according to the pattern of mucin expression as described below.
Cell Lines and Cell Culture
Five gastric carcinoma cell lines (MKN45, KATOIII, GP202, GP220, and AGS) were studied. GP202 and GP220 cell lines were established in our laboratory (Gartner et al. 1996). MKN45 was obtained from the Japanese Collection of Research Bioresources (JCRB; Osaka, Japan). KATOIII and AGS are commercially available cell lines (American Type Culture Collection; Rockville, MD).
Cell lines were grown in RPMI 1640 with Glutamax and supplemented with 10% inactive FBS and 50 µg/ml gentamicin. Cultures were maintained at 37C in a humidified 5% CO2 atmosphere.
Monoclonal Antibodies, Immunohistochemistry, and Immunofluorescence
Monoclonal antibodies (MAbs) used in this study, their specificity, and references are listed in Table 1
. Immunohistochemistry was performed using the avidin–biotin complex method. Paraffin sections were dewaxed and rehydrated. Samples designated for MUC2 staining were pretreated with neuraminidase for exposure of the epitope detected by antibody PMH1 (Reis et al. 1998).
|
Neuraminidase from Clostridium perfringens type IV (Sigma; St Louis, MO) was used diluted in 0.1 M sodium acetate buffer (pH 5.5) to a final concentration of 0.1 U/ml. Incubation was carried out for 2 hr at 37C and was followed by three washes in cold water. Sections were treated with 0.5% hydrogen peroxide in methanol for 30 min, washed with TBS, pH 7.6, and followed by a 20-min incubation with rabbit non-immune serum diluted 1:5 in TBS containing 10% BSA. Sections were washed and incubated overnight at 4C with MAbs (Table 1) diluted in TBS containing 5% of BSA. Sections were washed three times in TBS, incubated with a biotin-labeled rabbit anti-mouse secondary antibody diluted 1:200 in TBS for 30 min, washed in TBS, and incubated with avidin–biotin–peroxidase complex for 1 hr. Sections were washed and stained for 7 min with 0.05% DAB freshly prepared in 0.05 M Tris/hydroxymethylaminomethane buffer, pH 7.6, containing 0.1% hydrogen peroxide. Negative controls were performed using conjugated secondary antibody alone. Control for neuraminidase treatment was performed by incubating the section without enzyme.
Single immunofluorescence labeling was performed in cell lines fixed in acetone for 5 min. Samples were washed twice in TBS and incubated for 20 min with rabbit non-immune serum diluted 1:5 in TBS containing 10% BSA. Samples were washed in TBS and incubated overnight at 4C with MAbs diluted in TBS containing 5% BSA. Sections were washed three times for 5 min in TBS and incubated with FITC-conjugated rabbit anti-mouse immunoglobulin (Code F-261; Dako, Glostrup, Denmark) diluted 1:70 in TBS.
Samples designated for double-labeling immunofluorescence were treated as described above for single immunofluorescence labeling, followed by washing twice for 5 min in TBS and blocked with non-immune goat serum diluted 1:10 in TBS. Sections were incubated with MAbs PMH1 or HIK1083 (mouse IgM; Table 1) overnight at 4C. Sections were washed three times for 5 min with TBS and incubated for 45 min with Texas red-conjugated goat anti-mouse IgM (Jackson Immunoresearch Laboratories; West Grove, PA) diluted 1:50 in TBS. Sections were washed three times for 5 min in TBS and with DAPI, 20 min in the dark. Samples were washed three times for 5 min in TBS and mounted in Vectashield (Vector Laboratories; Burlingame, CA).
|
Results |
|---|
|
TopSummaryIntroductionMaterials and MethodsResultsDiscussionLiterature Cited |
|---|
Expression of Mucins and Carbohydrate Antigens (Terminal
1,4-GlcNAc and Sialyl-Tn) in Normal Gastric MucosaNormal gastric mucosa showed a consistent expression of MUC5AC in superficial foveolar cells and MUC6 in mucous neck cells of the body and deeper glands of the antrum (Figure 1A ). MUC1 was observed in the superficial foveolar cells of the antrum and in oxynthic glands of the body. MUC2 and MUC5B were not detected in normal gastric mucosa (Figure 1A).
|
Expression of terminal
1,4-GlcNAc was restricted to mucous neck cells of the body and deeper glands of the antrum (Figure 1A and Figure 2A
). Expression of terminal 1,4-GlcNAc did not fully colocalize with MUC6. Immunostaining of terminal 1,4-GlcNAc was observed throughout the cytoplasm and membrane, whereas MUC6 immunostaining was restricted to the perinuclear area of the cytoplasm. Expression of sialyl-Tn antigen was not detected in normal gastric mucosa.
|
Expression of Mucins and Carbohydrate Antigens (Terminal
1,4-GlcNAc and Sialyl-Tn) in Complete and Incomplete Intestinal MetaplasiaThe 22 cases of IM were classified as complete IM (n=14) or incomplete IM (n=8) according to the pattern of expression of mucins (Reis et al. 1999
). The cases with complete IM showed absence of expression of gastric mucins MUC5AC, MUC6, and MUC1 and expression of the intestinal mucin MUC2 (Figure 1B and Figure 2C). The cases with incomplete IM showed coexpression of "gastric mucins" MUC5AC, MUC6, and MUC1 together with the intestinal mucin MUC2 (Figure 1B and Figure 2F). Both complete and incomplete IM showed absence of expression of MUC5B (Figure 1B).
Results of the expression of terminal 1,4-GlcNAc and sialyl-Tn antigen are summarized in Figure 1B. The 11 foci of complete IM showed no expression of terminal 1,4-GlcNAc as detected by HIK1083. Expression of sialyl-Tn was detected in all cases of incomplete IM.
In incomplete IM, most foci were negative for terminal 1,4-GlcNAc, and only one case showed a single metaplastic gland of the incomplete IM type with expression of terminal 1,4-GlcNAc. Expression of sialyl-Tn was detected in all cases with incomplete IM.
Expression of Mucins and Carbohydrate Antigens (Terminal 1,4-GlcNAc and Sialyl-Tn) in Gastric Carcinoma Cell Lines
Expression of carbohydrate antigens is summarized in Table 2
. Terminal 1,4-GlcNAc was absent in all gastric cell lines studied. Low levels of expression of sialyl-Tn were detected in MKN45 cells.
|
Expression of MUC5AC was detected in <25% of MKN45, KATOIII, and GP220 cells. A diffuse cytoplasmic staining pattern was observed. None of the gastric cell lines studied showed expression of the intestinal mucin MUC2 (Table 2).
|
Discussion |
|---|
|
TopSummaryIntroductionMaterials and MethodsResultsDiscussionLiterature Cited |
|---|
Development of IM in human stomach creates a microenvironment that is hostile to the bacterial colonization leading to the clearing of Hp from metaplastic glands (Craanen et al. 1992
; Genta et al. 1996). Given the role that carbohydrate structures play in the adhesion and/or colonization of Hp, we characterized the alteration of two carbohydrate structures, terminal 1,4-GlcNAc and sialyl-Tn antigen, in both complete and incomplete IM to evaluate whether these glycans are implicated in the process of Hp clearance from metaplastic glands.
Evaluation of terminal 1,4-GlcNAc in normal gastric mucosa confirmed previous studies (Nakamura et al. 1998,1999; Zhang et al. 2001) showing that terminal 1,4-GlcNAc was restricted to the mucous cells of the glands of the gastric mucosa with absence of expression in the foveolar superficial gastric epithelium. These observations are in agreement to the hypothesis that the expression of terminal 1,4-GlcNAc in gastric glands creates hostile conditions for Hp colonization in deep gastric mucous cells of the glands. This antimicrobial activity of terminal 1,4-GlcNAc against Hp has been shown to stem from the inhibition of the biosynthesis of cholesteryl--D-glucopyranoside, a major cell wall component of the bacteria (Kawakubo et al. 2004).
Comparison of expression of mucins and carbohydrate antigens in normal gastric mucosa shows that both MUC6 and terminal 1,4-GlcNAc are expressed in mucous cells of the glands of the gastric mucosa but do not fully colocalize at the tissue and cellular level. Lack of overlap in the immunocytolocalization pattern may be due to variability of the type and rate of glycosylation of MUC6 mucin, which in some cases displays glycoforms that may not be detected by the MAb CLH5 (Reis et al. 2000) but still express terminal 1,4-GlcNAc.
We did not observe expression of the simple mucin-type carbohydrate antigen sialyl-Tn in normal gastric mucosa in agreement with what was previously described (David et al. 1992). This is in keeping with data showing that sialyl-Tn is a carbohydrate structure rarely expressed in normal tissues, despite its ability to be detected in normal intestinal mucosa where it shows restricted expression in the goblet cells (Itzkowitz et al. 1990).
The almost exclusive colonization of Hp of the gastric mucosa and the localized adherence restricted to the surface foveolar cells (Hidaka et al. 2001; Teixeira et al. 2002) suggest that Hp colonization is dependent on the gastric microenvironment. Development of IM in the stomach is characterized by extensive modifications in the profile of mucins (Reis et al. 1999) and mucin-glycosylation (Torrado et al. 1990; Mullen et al. 1995; Silva et al. 2002; Bodger et al. 2003). In the present study we characterized the expression of mucins MUC1, MUC2, MUC5AC, MUC5B, and MUC6 using specific MAbs. Detection of MUC2 was performed using the MAb PMH1, which detects MUC2-GalNAc (Reis et al. 1998). To ensure the exposure of the PMH1 epitope and its detection, we performed the removal of NeuAc by submitting the tissue sections to neuraminidase treatment as previously described (Reis et al. 1998,1999). Neuraminidase treatment did not affect the immunostaining obtained with the antibodies directed to MUC1, MUC5AC, MUC5B, MUC6, or 1,4-GlcNAc; therefore, neuraminidase treatment was unnecessary with these antibodies (data not shown).
Characterization of the pattern of mucin expression in IM disclosed two major types: (a) the complete IM showing absence of expression of gastric mucins (MUC5AC, MUC6, and MUC1) and de novo expression of the intestinal mucin MUC2 and (b) the incomplete IM displaying a coexpression of "gastric mucins" MUC5AC, MUC6, and MUC1 together with the intestinal mucin MUC2 (Reis et al. 1999). The present study also confirmed previous observations showing that MUC5B is not expressed in normal gastric mucosa or in intestinal metaplasia (Perrais et al. 2001; Pinto-de-Sousa et al. 2004).
We, and others, have shown that most areas of IM show no Hp colonization (Genta et al. 1996; Bravo and Correa 1999; Teixeira et al. 2002), and we have previously characterized that the frequency of Hp colonization in complete and incomplete IM is 0% and 25%, respectively (Teixeira et al. 2002). We also observed that, in these rare positive cases, Hp colonization was restricted to small IM foci lacking MUC2 expression. These observations, together with evidence of the role that carbohydrate structures play in the colonization by Hp, led us to the characterization of complete and incomplete IM with respect to carbohydrate structures: terminal 1,4-GlcNAc and sialyl-Tn antigen.
Contrary to the normal gastric mucosa, which showed a consistent expression of terminal 1,4-GlcNAc in the gastric glands, we observed no expression of this glycan in IM. Both complete and incomplete IM were negative for terminal 1,4-GlcNAc. One case of incomplete IM was an exception showing a single metaplastic gland with expression of terminal 1,4-GlcNAc among several metaplastic glands showing no expression of terminal 1,4-GlcNAc. The general absence of expression of terminal 1,4-GlcNAc in IM observed in the present study demonstrates that this carbohydrate structure is not responsible for the absence of colonization of Hp observed in metaplastic glands (Craanen et al. 1992; Teixeira et al. 2002). Other mechanisms, such as absence of ligands for Hp adhesins, together with the aberrant expression of MUC2 and sialyl-Tn, may determine major modifications in IM contributing to the creation of a hostile microenvironment for Hp colonization of metaplastic glands.
The sialyl-Tn antigen, a carbohydrate structure normally expressed in intestinal mucosa, was observed in all cases of both complete and incomplete IM. Sialyl-Tn expression was localized in goblet cells, and double-labeling immunofluorescence demonstrated a consistent overlapping between sialyl-Tn and MUC2 expression (Figures 2E and 2H). The consistent expression of sialyl-Tn and MUC2 in all IM cases suggests that either or both can be implicated in Hp clearance from the gastric mucosa with IM lesions.
Given the antimicrobial effect that terminal 1,4-GlcNAc may exert (Kawakubo et al. 2004), it is important to characterize the expression of this glycan in cell lines used for coculture experiments with Hp. We have observed that Hp can adhere and be cocultured with gastric cell lines MKN45, AGS, and GP202 (unpublished data), which do not express terminal 1,4-GlcNAc. However, Kawakubo et al. (2004) demonstrated that when Hp was cocultured with the cell line AGS transfected with 4GlcNAc-transferase and expressing 1,4-GlcNAc, Hp growth was markedly suppressed, and the cellular damage induced by Hp was barely detected. These observations demonstrate that gastric cells expressing 1,4-GlcNAc-capped O-glycans protect themselves against Hp infection. Our results showed no expression of terminal 1,4-GlcNAc with the gastric carcinoma cell lines studied (Table 2), demonstrating that the cell lines used in the present and in previous studies (Lee et al. 2004; Keates et al. 2005) are suitable models for Hp coculture/adhesion experiments.
Our results are identical to previous studies with the same cell lines except for slight discrepancies regarding levels of mucin expression in the cell lines when compared with previous studies (Carvalho et al. 1999; Basque et al. 2001). This variability among studies may stem from the different confluence levels of the cell culture at the time of immunocytology sampling.
In conclusion, terminal 1,4-GlcNAc was not detected in IM except in a single foci of one case, indicating that this structure is not implicated in the clearance of Hp from IM, in contrast to what is observed in normal gastric mucosa. None of the gastric carcinoma cell lines studied showed terminal 1,4-GlcNAc, suggesting they do not display a gastric gland mucous cell phenotype and therefore are useful models for in vitro Hp studies. Finally, sialyl-Tn antigen colocalizes with MUC2 mucin and is present in all cases of complete and incomplete IM, suggesting that either or both can be implicated in Hp clearance from IM.
|
Acknowledgments |
|---|
This work was supported by Fundação para a Ciência e a Tecnologia (FCT, POCI/SAU-OBS/56686/2004) and Association for International Cancer Research (Grant 05-088). N.M. acknowledges Fundação para a Ciência e a Tecnologia (FCT, Ref. SFRH/BD/11764/2003) for financial support.
We thank Nuno Mendes and Paula Silva for technical assistance. We thank Prof. Dallas Swallow for providing antibody EU-MUC5Ba and Dr. Joy Burchell and Prof. Joyce Taylor-Papadimitriou for providing antibody HMFG1.
|
Footnotes |
|---|
Received for publication September 14, 2005; accepted December 22, 2005
|
Literature Cited |
|---|
|
TopSummaryIntroductionMaterials and MethodsResultsDiscussionLiterature Cited |
|---|
Basque JR, Chenard M, Chailler P, Menard D (2001) Gastric cancer cell lines as models to study human digestive functions. J Cell Biochem 81:241–251[CrossRef][Medline]
Bodger K, Campbell F, Rhodes JM (2003) Detection of sulfated glycoproteins in intestinal metaplasia: a comparison of traditional mucin staining with immunohistochemistry for the sulfo-Lewis(a) carbohydrate epitope. J Clin Pathol 56:703–708
Bravo JC, Correa P (1999) Sulphomucins favour adhesion of Helicobacter pylori to metaplastic gastric mucosa. J Clin Pathol 52:137–140[Abstract]
Carvalho F, David L, Aubert JP, Lopez-Ferrer A, De Bolos C, Reis CA, Gartner F, et al. (1999) Mucins and mucin-associated carbohydrate antigens expression in gastric carcinoma cell lines. Virchows Arch 435:479–485[Medline]
Corfield AP, Carroll D, Myerscough N, Probert CS (2001) Mucins in the gastrointestinal tract in health and disease. Front Biosci 6:D1321–1357.[Medline]
Correa P (1992) Human gastric carcinogenesis: a multistep and multifactorial process. First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 52:6735–6740
Craanen ME, Blok P, Dekker W, Ferwerda J, Tytgat GN (1992) Subtypes of intestinal metaplasia and Helicobacter pylori. Gut 33:597–600
David L, Nesland JM, Clausen H, Carneiro F, Sobrinho-Simoes M (1992) Simple mucin-type carbohydrate antigens (Tn, sialosyl-Tn and T) in gastric mucosa, carcinomas and metastases. APMIS Suppl 27:162–172[Medline]
Futami H, Takashima M, Furuta T, Hanai H, Kaneko E (1999) Relationship between Helicobacter pylori infection and gastric metaplasia in the duodenal bulb in the pathogenesis of duodenal ulcer. J Gastroenterol Hepatol 14:114–119[CrossRef][Medline]
Gartner F, David L, Seruca R, Machado JC, Sobrinho-Simoes M (1996) Establishment and characterization of two cell lines derived from human diffuse gastric carcinomas xenografted in nude mice. Virchows Arch 428:91–98[Medline]
Genta RM, Gurer IE, Graham DY, Krishnan B, Segura AM, Gutierrez O, Kim JG, et al. (1996) Adherence of Helicobacter pylori to areas of incomplete intestinal metaplasia in the gastric mucosa. Gastroenterology 111:1206–1211[Medline]
Hidaka E, Ota H, Hidaka H, Hayama M, Matsuzawa K, Akamatsu T, Nakayama J, et al. (2001) Helicobacter pylori and two ultrastructurally distinct layers of gastric mucous cell mucins in the surface mucous gel layer. Gut 49:474–480
Ilver D, Arnqvist A, Ogren J, Frick IM, Kersulyte D, Incecik ET, Berg DE, et al. (1998) Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 279:373–377
Ishihara K, Kurihara M, Goso Y, Urata T, Ota H, Katsuyama T, Hotta K (1996) Peripheral -linked N-acetylglucosamine on the carbohydrate moiety of mucin derived from mammalian gastric gland mucous cells: epitope recognized by a newly characterized monoclonal antibody. Biochem J 318:409–416
Itzkowitz SH, Bloom EJ, Kokal WA, Modin G, Hakomori S, Kim YS (1990) Sialosyl-Tn. A novel mucin antigen associated with prognosis in colorectal cancer patients. Cancer 66:1960–1966[CrossRef][Medline]
Kawakubo M, Ito Y, Okimura Y, Kobayashi M, Sakura K, Kasama S, Fukuda MN, et al. (2004) Natural antibiotic function of a human gastric mucin against Helicobacter pylori infection. Science 305:1003–1006
Keates S, Keates AC, Nath S, Peek RM, Kelly CP (2005) Transactivation of the EGFR by cag+ Helicobacter pylori induces upregulation of the early growth response gene Egr-1 in gastric epithelial cells. Gut 54:1363–1369
Lee KH, Cho MJ, Yamaoka Y, Graham DY, Yun YJ, Woo SY, Lim CY, et al. (2004) Alanine-threonine polymorphism of Helicobacter pylori RpoB is correlated with differential induction of interleukin-8 in MKN45 cells. J Clin Microbiol 42:3518–3524
Mahdavi J, Sonden B, Hurtig M, Olfat FO, Forsberg L, Roche N, Angstrom J, et al. (2002) Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science 297:573–578
Mullen PJ, Carr N, Milton JD, Rhodes JM (1995) Immunohistochemical detection of O-acetylated sialomucins in intestinal metaplasia and carcinoma of the stomach. Histopathology 27:161–167[Medline]
Nakamura N, Ota H, Katsuyama T, Akamatsu T, Ishihara K, Kurihara M, Hotta K (1998) Histochemical reactivity of normal, metaplastic, and neoplastic tissues to -linked N-acetylglucosamine residue-specific monoclonal antibody HIK1083. J Histochem Cytochem 46:793–801
Nakayama J, Yeh JC, Misra AK, Ito S, Katsuyama T, Fukuda M (1999) Expression cloning of a human 1,4-N-acetylglucosaminyltransferase that forms GlcNAc14GalßR, a glycan specifically expressed in the gastric gland mucous cell-type mucin. Proc Natl Acad Sci USA 96:8991–8996
Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK (1991) Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325:1127–1131[Abstract]
Perrais M, Pigny P, Buisine MP, Porchet N, Aubert JP, Seuningen-Lempire I (2001) Aberrant expression of human mucin gene MUC5B in gastric carcinoma and cancer cells. Identification and regulation of a distal promoter. J Biol Chem 276:15386–15396
Pinto-de-Sousa J, Reis CA, David L, Pimenta A, Cardoso-de-Oliveira M (2004) MUC5B expression in gastric carcinoma: relationship with clinico-pathological parameters and with expression of mucins MUC1, MUC2, MUC5AC and MUC6. Virchows Arch 444:224–230[Medline]
Reis CA, David L, Carvalho F, Mandel U, De Bolos C, Mirgorodskaya E, Clausen H, et al. (2000) Immunohistochemical study of the expression of MUC6 mucin and co-expression of other secreted mucins (MUC5AC and MUC2) in human gastric carcinomas. J Histochem Cytochem 48:377–388
Reis CA, David L, Correa P, Carneiro F, De Bolos C, Garcia E, Mandel U, et al. (1999) Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res 59:1003–1007
Reis CA, David L, Nielsen PA, Clausen H, Mirgorodskaya K, Roepstorff P, Sobrinho-Simoes M (1997) Immunohistochemical study of MUC5AC expression in human gastric carcinomas using a novel monoclonal antibody. Int J Cancer 74:112–121[CrossRef][Medline]
Reis CA, Sorensen T, Mandel U, David L, Mirgorodskaya E, Roepstorff P, Kihlberg J, et al. (1998) Development and characterization of an antibody directed to an -N-acetyl-D-galactosamine glycosylated MUC2 peptide. Glycoconj J 15:51–62[CrossRef][Medline]
Rousseau K, Wickstrom C, Whitehouse DB, Carlstedt I, Swallow DM (2003) New monoclonal antibodies to non-glycosylated domains of the secreted mucins MUC5B and MUC7. Hybrid Hybridomics 22:293–299[CrossRef][Medline]
Silva E, Teixeira A, David L, Carneiro F, Reis CA, Sobrinho-Simoes J, Serpa J, et al. (2002) Mucins as key molecules for the classification of intestinal metaplasia of the stomach. Virchows Arch 440:311–317[CrossRef][Medline]
Suerbaum S, Michetti P (2002) Helicobacter pylori infection. N Engl J Med 347:1175–1186
Taylor-Papadimitriou J, Peterson JA, Arklie J, Burchell J, Ceriani RL, Bodmer WF (1981) Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: production and reaction with cells in culture. Int J Cancer 28:17–21[Medline]
Teixeira A, David L, Reis CA, Costa J, Sobrinho-Simoes M (2002) Expression of mucins (MUC1, MUC2, MUC5AC, and MUC6) and type 1 Lewis antigens in cases with and without Helicobacter pylori colonization in metaplastic glands of the human stomach. J Pathol 197:37–43[Medline]
Torrado J, Blasco E, Gutierrez-Hoyos A, Cosme A, Lojendio M, Arenas JI (1990) Lewis system alterations in gastric carcinogenesis. Cancer 66:1769–1774[CrossRef][Medline]
Wang CC, Wu MS, Wang HH, Wang HP, Lee WC, Shun CT, Lin JT (1998) Helicobacter pylori infection and age on the development of intestinal metaplasia—a multiple logistic regression analysis. Hepatogastroenterology 45:2234–2237[Medline]
Zhang MX, Nakayama J, Hidaka E, Kubota S, Yan J, Ota H, Fukuda M (2001) Immunohistochemical demonstration of 1,4-N-acetylglucosaminyltransferase that forms GlcNAc1,4Galß residues in human gastrointestinal mucosa. J Histochem Cytochem 49:587–596
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  A S Mall Analysis of mucins: role in laboratory diagnosis J. Clin. Pathol., September 1, 2008; 61(9): 1018 - 1024. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Guidelines | Subscriptions | About | exPRESS - Current - Archive | Business Information | Contact |